Literature DB >> 28890875

Cyanotic congenital heart diseases among Nigerian children.

Barakat Adeola Animasahun1,2, Akpoembele Deborah Madise-Wobo2, Olusola Yejide Kusimo3.   

Abstract

BACKGROUND: There are only few reports on cyanotic congenital heart diseases (CCHD) among Nigerian and African Children. The current report aim to provide the most recent hospital based data on the distribution of CCHD in children less than 14 years of age, the demographic characteristics and risk factors identified.
METHODS: Prospective and cross-sectional involving consecutive cases of CCHD diagnosed with echocardiography at the Lagos State University Teaching Hospital between January 2007 and June 2016. Data were analyzed using Statistical Package for Social Sciences (SPSS) version 20. Level of significance set at P<0.05.
RESULTS: There were 352 subjects with CCHD with a male to female ratio of 1.34:1. The children were age 2 days to 14 years with a mean ± SD of 38.62±44.74 months and median of 21 months. The most common type of CCHD (both isolated and multiple CCHD) was tetralogy of Fallot (TOF) followed double outlet right ventricle (DORV) and transposition of the great arteries (TGA). The most common mode of presentation was cyanosis.
CONCLUSIONS: TOF was found in almost half of the subjects. Cases of DORV which have been rarely reported were more than those with TGA. Most were diagnosed late. Cyanosis was the most common mode of presentation. Clinical features are protean; thus a high index of suspicion is required to make an early diagnosis.

Entities:  

Keywords:  Cyanotic; Nigeria; children; congenital heart disease

Year:  2017        PMID: 28890875      PMCID: PMC5582056          DOI: 10.21037/cdt.2017.06.03

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  29 in total

1.  Congenital heart disease in 56,109 births. Incidence and natural history.

Authors:  S C Mitchell; S B Korones; H W Berendes
Journal:  Circulation       Date:  1971-03       Impact factor: 29.690

2.  Tetralogy of Fallot in the fetus in the current era.

Authors:  L C Y Poon; I C Huggon; V Zidere; L D Allan
Journal:  Ultrasound Obstet Gynecol       Date:  2007-06       Impact factor: 7.299

3.  Congenital heart disease in Nigerian children: a multicenter echocardiographic study.

Authors:  Wilson E Sadoh; Chinyere C Uzodimma; Queennette Daniels
Journal:  World J Pediatr Congenit Heart Surg       Date:  2013-04

4.  Congenital heart defects and parental occupational exposure to chemicals.

Authors:  Claudia A Snijder; Ingrid J Vlot; Alex Burdorf; Sylvia A Obermann-Borst; Willem A Helbing; Mark F Wildhagen; Eric A P Steegers; Régine P M Steegers-Theunissen
Journal:  Hum Reprod       Date:  2012-02-22       Impact factor: 6.918

5.  Congenital heart disease in Saudi Arabia: current epidemiology and future projections.

Authors:  A A A Alabdulgader
Journal:  East Mediterr Health J       Date:  2006       Impact factor: 1.628

6.  Caregivers of Children with Congenital Heart Disease: Does Socioeconomic Class Have Any Effect on Their Perceptions?

Authors:  Adeola Animasahun; Omolara Kehinde; Olabode Falase; Olumuyiwa Odusanya; Fidelis Njokanma
Journal:  Congenit Heart Dis       Date:  2014-09-08       Impact factor: 2.007

7.  Epidemiology of Congenital Heart Disease in India.

Authors:  Ritu Dixit; Sunil Kumar Rai; Abhishek Kumar Yadav; Siddharth Lakhotia; Damyanti Agrawal; Ashok Kumar; Bhagyalaxmi Mohapatra
Journal:  Congenit Heart Dis       Date:  2014-09-08       Impact factor: 2.007

8.  Population-based study of antenatal detection of congenital heart disease by ultrasound examination.

Authors:  C Chew; J L Halliday; M M Riley; D J Penny
Journal:  Ultrasound Obstet Gynecol       Date:  2007-06       Impact factor: 7.299

9.  The cost of open heart surgery in Nigeria.

Authors:  Bode Falase; Michael Sanusi; Adetinuwe Majekodunmi; Ifeoluwa Ajose; Ariyo Idowu; David Oke
Journal:  Pan Afr Med J       Date:  2013-02-12

Review 10.  The global burden of congenital heart disease.

Authors:  Julien Ie Hoffman
Journal:  Cardiovasc J Afr       Date:  2013-05       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.